Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?

Int Braz J Urol. 2015 Mar-Apr;41(2):329-36. doi: 10.1590/S1677-5538.IBJU.2015.02.21.

Abstract

Purpose: We investigated the effect of antibiotics on PSA in asymptomatic patients with mild PSA elevation.

Materials and methods: We prospectively evaluated, in a non-randomized design, 106 asymptomatic patients with PSA of 4-10 ng/mL, with a negative digital rectal examination and with no urinary tract infection evidence for 2 years. Patients were divided into two groups: those treated with antibiotics for 3 weeks (G1) and those who were not treated (G2). PSA was taken six weeks after and prostate biopsy was performed in all patients.

Results: PCa was diagnosed in 25 of 106 patients (23.6%): 16 (25.0%) in G1 and 9 (21.4%) in G2 (p>0.05). PSA normalization was experienced in 24.5%. In G1, PSA returned to <4 ng/mL in 15 (23.4%) patients compared to 11 (26%) patients in G2. In the patients with a positive biopsy, no significant variation was noted in PSA, fPSA, %fPSA and DPSA after antibiotic treatment. A significantly lower cancer detection rate was noted with decreased PSA, fPSA, and DPSA after antibiotic use. A PSA reduction rate of ≥ 10% occurred in 58.5%, and this was similar in both G1 and G2 groups. The sensibility, specificity and accuracy of PSA reduction of ≥ 10% were 31%, 23% and 25%, respectively.

Conclusion: Empirical antibiotic therapy in asymptomatic male patients is not related to PSA reduction. The greater than 10% PSA reduction after antibiotic in this population cannot postpone prostate biopsy.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Biopsy
  • Ciprofloxacin / therapeutic use*
  • Digital Rectal Examination
  • Early Detection of Cancer
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Prostate / pathology*
  • Prostate-Specific Antigen / blood*
  • Prostate-Specific Antigen / drug effects
  • Prostatic Neoplasms / pathology*
  • Prostatitis / drug therapy*
  • Reference Values
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Prostate-Specific Antigen